Product Name: Sorafenib
Generic Name: Sorafenib
Common Brands: Nexavar, Sorafenat, Soranib
Pharmaceutical Categories: Cancer
Where to buy Sorafenib online:
|Shop | Product | Forms | Strength | Conditions
|MEDS FOR SALE|
|Nexavar tablets 200 mg||5% discount coupon: 5OFFPayment: Visa, Mastercard, AmEx, BitcoinShipping: worldwideDelivery: unregistered mail, trackable courier|
|PHARM X SELLER|
|Soranib tablets 200 mg||10% discount coupon: 918cc60b466a42baPayment: PayBis, Cryptocurrency, MG, WU, ZelleShipping: worldwideDelivery: registered airmail, FedEx, DHL
Sorafenib (trade names include Nexavar, Sorafenat, Soranib, Soranix) is an anti-cancer drug from protein kinase inhibitors pharmacological group. This medication is used for the treatment of advanced primary liver cancer (hepatocellular carcinoma), primary kidney cancer (advanced renal cell carcinoma, advanced renal cancer), FLT3-ITD positive AML and radioactive iodine resistant advanced thyroid carcinoma. It is in researcj studies for the treatment of lung, brain (recurrent glioblastoma), ovarian cancer, desmoid tumor (aggressive fibromatosis). It works by inhibiting protein kinases enzymes in cancer cells.
Customers also buy these medications from the same pharmacological classes:
Pharmaceutical and medical classifications:
Anti cancer drugs
Anti tumor medicines
Medications for the treatment of liver tumors
Tyrosine kinase inhibitors
The Anatomical Therapeutic Chemical (ATC) classification system (developed by the World Health Organization):
L - Antineoplastic and immunomodulating agents
L01 - Antineoplastic agents
L01X - Other antineoplastic agents
L01XE - Protein kinase inhibitors
L01XE05 - Sorafenib
Medical conditions for sorafenib in the International Statistical Classification of Diseases and Related Health Problems:
Malignant neoplasm of liver and intrahepatic bile ducts - C22
Liver cell carcinoma - C22.0
Malignant neoplasm of bronchus and lung - C34
Malignant neoplasm of ovary - C56
Malignant neoplasm of kidney, except renal pelvis - C64
Malignant neoplasm of brain - C71
Malignant neoplasm of thyroid gland - C73
Neoplasm of uncertain behavior of other and unspecified sites - D48
Fibroblastic disorders - M72
D - Australia
D - United States (Positive evidence of risk)
Forms of active pharmaceutical ingredients (APIs):
Chemical, international, and other names of this drug:
Most known trade names (brands and generics) worldwide:
Nexavar - Bayer, Onyx Pharmaceuticals
Sorafenat - Natco Pharma
Soranib - Cipla
Soranix - Beacon Pharmaceuticals
References and external sources:
Sorafenib main article on Wikipedia: https://en.wikipedia.org/wiki/Sorafenib
Sorafenib compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Sorafenib
Sorafenib Tosylate compound on PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Sorafenib-tosylate
Sorafenib medicine on DrugBank: https://www.drugbank.ca/drugs/DB00398
Sorafenib Tosylate on DrugBank: https://www.drugbank.ca/salts/DBSALT000165
Sorafenib FAQ on MedlinePlus (revised 02/15/2019): https://medlineplus.gov/druginfo/meds/a607051.html
Nexavar (Sorafenib Tosylate) film-coated tablets drug label on DailyMed (revised July 9, 2020): https://dailymed.nlm.nih.gov/dailymed/lookup...
Nexavar (Sorafenib Tosylate) tablets for oral use official prescribing and patient information from the U.S. FDA (revised 07/2020): https://www.accessdata.fda.gov/drugsatfda_docs/label...
Nexavar (Sorafenib Tosylate) tablets 200 mg product monograph from Bayer pharmaceutical company (revised 07/2020): https://www.bayer.com/sites/default/files/...
Nexavar (Sorafenib Tosylate) tablets official website powered by Bayer (for U.S. audiences only): https://www.nexavar-us.com/
Nexavar (Sorafenib Tosylate) tablets official website for healthcare professionals (for U.S. audiences only): https://www.hcp.nexavar-us.com/
Nexavar (Sorafenib Tosylate) 200 mg film-coated tablets package information leaflet Medicines.org.uk (revised 09/2019): https://www.medicines.org.uk/emc/files/pil.226.pdf
Soranib (Sorafenib Tosylate, Nexavar generic) 200 mg film-coated tablets prescribing information from Cipla company (revised December 2017): https://www.ciplamed.com/content/soranib-tablets
Revised: May 2022
Disclaimer: Please note, this website is not an online pharmacy, drugstore and related online pharma shop. It does not sell, supply or advertise any prescription and OTC drugs, medications, other goods and services. All reviews, links, lists, databases, texts, and other content on the website are provided free and only for informational and educational purposes. Medical content on this website, including drug names, indications, contraindication, side effects, categories, classifications, forms, doses, prices, other health and pharmaceutical information are taken only from trusted and authoritative professional sources (see "References"), reviewed and prepared by our licensed experts, content inspectors and editors.
You should always consult your doctor or other healthcare professional before using any medication. This website, our staff and support do not provide own medical instructions and advices.
All brands and trade names appearing on the website are registered trademarks and intellectual property of their respective companies.
Remember that buying drugs and medicines online is a responsibility only of customers, sellers and suppliers regarding existing legislation in their jurisdictions.
Share us in social media: